Steven L. Tuch - Feb 27, 2024 Form 4 Insider Report for vTv Therapeutics Inc. (VTVT)

Role
Chief Financial Officer
Signature
/s/ Paul J. Sekhri as Attorney-in-Fact
Stock symbol
VTVT
Transactions as of
Feb 27, 2024
Transactions value $
$734,098
Form type
4
Date filed
6/13/2024, 04:38 PM
Previous filing
Dec 13, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTVT Employee stock option (right to buy) Award $734K +62.2K +497.27% $11.81 74.7K Feb 27, 2024 Class A Common Stock 62.2K $11.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in quarterly equal installments over the three year period beginning on February 27, 2024. The option was conditioned upon shareholder approval of the 2024 Equity Incentive Plan, which was approved by the shareholders on June 11, 2024.